Global Health IPO - Multi-Speciality Tertiary Care Providers; Strong North India Presence: Reliance Securities
Medanta is coming out with an IPO comprising fresh issue of ~14.9 million shares and OFS of ~50.8 million shares.
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Reliance Securities' IPO Report
Global Health Ltd. operates under the brand ‘Medanta’ is one of the largest private multi-speciality tertiary care providers with a strong presence in the North and East regions of India.
The company engages in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant and kidney and urology.
As of Jun‘22, the company provides healthcare services with over 30 medical specialities supported by 1,300 doctors. It has an expansive area of 4.7 million square feet and the operational hospitals having 2,467 installed beds.
Medanta is coming out with an initial public offering comprising fresh issue of ~14.9 million shares and offer for sale of ~50.8 million shares, aggregating a total of ~Rs 22 billion.
Click on the attachment to read the full IPO report:
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.